Delivery Order 36F79722D0165-36C24526N0688

<p>Veterans Integrated Service Network 5 issued a $11,948.16 delivery order to Ardelyx, Inc. on June 26, 2026, for XPHOZAH 30 mg under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed price with an ultimate completion date of June 30, 2026. Place of performance is Dublin, OH. No set-aside was used.</p>

<p>Veterans Integrated Service Network 5 issued a $3,998.50 delivery order to Ardelyx, Inc. on June 12, 2026, for XPHOZAH 20 mg under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed price with an ultimate completion date of June 16, 2026. Place of performance is Dublin, OH. No set-aside was used.</p>

Veterans Integrated Service Network 5 issued a $2,016.52 delivery order to Ardelyx, Inc. on December 31, 2025, for XPHOZAH 30 mg under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed price with no set-aside designation. Place of performance is Dublin, OH. The ultimate completion date is January 2, 2026. The Federal Supply Schedule provides the parent vehicle framework for VA medical centers nationwide to procure specialized medications for veterans with...

Ardelyx, Inc., a pharmaceutical company based in Fremont, California, was awarded a delivery order for XPHOZAH 30 mg by Veterans Integrated Service Network 5 (VISN 5), a component of the Department of Veterans Affairs. This contract, valued at $2,016.52, represents a firm fixed-price delivery order issued on September 19, 2025, with an ultimate completion date of September 23, 2025. The award is performed under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and will be...

This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Ardelyx, Inc., a for-profit pharmaceutical company, to provide the drug XPHOZAH [TENAPANOR] to VA medical centers. The firm-fixed-price delivery orders, valued at $6,048.81 each, were issued under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Ardelyx currently holds two active Indefinite Delivery Vehicles (IDVs) under the same FSS schedule, enabling the company to...

This is a firm-fixed-price delivery order awarded to Ardelyx, Inc., a for-profit pharmaceutical company, by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract, valued at $16,133.49, is for the delivery of XPHOZAH (tenapanor), a medication used to treat hyperphosphatemia in patients on dialysis. The contract is part of a larger Blanket Purchase Agreement (BPA) valued at $32,500,000, which allows VA medical centers...

<p>Veterans Integrated Service Network 4 issued a purchase order to Cardinal Health 414, LLC on April 12, 2025, for Xofigo radiopharmaceutical with a ceiling value of $23,971.71. Performance takes place in Philadelphia, Pennsylvania. The order is firm fixed price with no set-aside designation and an ultimate completion date of April 11, 2026.</p>

Veterans Integrated Service Network 5 issued a delivery order to Travere Therapeutics, Inc. on June 24, 2026, for Filspari 400 mg with a ceiling value of $15,866.58, under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed price with no set-aside. Place of performance is Monroeville, PA. Ultimate completion date is June 26, 2026. The FSS-61-IB is a multiple-award federal supply schedule for pharmaceutical products under which the VA issues delivery...

The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order valued at $45.8K to Ferring Pharmaceuticals Inc. for the supply of Adstiladrin (nadofaragene firadenovec), an oncology medication used to treat genitourinary cancers in veterans. The contract, awarded on October 17, 2025, carries a firm-fixed price structure with an ultimate completion date of October 21, 2025, and will be performed at Ferring's location in Carrollton, TX. This...

<p>Veterans Integrated Service Network 22 issued a delivery order to Bayer Healthcare Pharmaceuticals Inc. on April 1, 2025, for Xofigo (radium Ra 223 dichloride) with a ceiling value of $12,667.52.</p> <p>The order is placed under the Department of Veterans Affairs' Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a multiple-award schedule contract. Place of performance is San Diego, CA 92161. The order is firm fixed price with an ultimate completion date of March 31, 2026.</p>